The DOI matches its Crossref record; 320 of the 339 references it cites were found in a registry or an index; none of the 253 sources its claims cite is checked for support yet.
Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Open accessAbstract
Melatonin has become a popular dietary supplement, most known as a chronobiotic, and for establishing healthy sleep. Research over the last decade into cancer, Alzheimer’s disease, multiple sclerosis, fertility, PCOS, and many other conditions, combined with the COVID-19 pandemic, has led to greater awareness of melatonin because of its ability to act as a potent antioxidant, immune-active agent, and mitochondrial regulator. There are distinct similarities between melatonin and vitamin D in the depth and breadth of their impact on health. Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness. In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light. The trend toward greater use of melatonin supplements has resulted in concern about its safety, especially higher doses, long-term use, and application in certain populations (e.g., children). This review aims to evaluate the recent data on melatonin’s mechanisms, its clinical uses beyond sleep, safety concerns, and a thorough summary of therapeutic considerations concerning dietary supplementation, including the different formats available (animal, synthetic, and phytomelatonin), dosing, timing, contraindications, and nutrient combinations.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review argues melatonin resembles vitamin D as a pleiotropic, light/dark-responsive hormone and reviews its mechanisms, clinical uses beyond sleep, safety, and supplement considerations. It emphasizes that melatonin is not simply a sleep aid, that dosing should generally be low and personalized, and that phytomelatonin may outperform synthetic melatonin in some in vitro assays.
Key findings
- The pineal gland produces about 0.1–0.9 mg melatonin daily, while gut enterochromaffin cells contain roughly 400 times more melatonin than the pineal gland, with gut levels 10–100 times greater than serum levels; production declines with age.
- In vitro, phytomelatonin showed 646% stronger COX-2 inhibition, 267–470% more potent free-radical scavenging, and 100% greater efficacy in reducing cellular ROS in a human skin cell line compared with synthetic melatonin.
- Clinical studies cited include 3 mg melatonin reducing migraine frequency comparably to amitriptyline; 10 mg nightly reducing endometriosis pain by about 40% and pain-medication use by 80%; six months of melatonin in PCOS decreasing androgens, free testosterone, hydroxyprogesterone, anti-Mullerian hormone, and LDL, with menstrual irregularities decreasing in 95%; and controlled-release melatonin reducing asleep systolic blood pressure by 3.57 mm Hg.
- Supplement quality and safety concerns include 31 over-the-counter melatonin products ranging from −83% to +478% of label claim, limited safety studies for high-dose melatonin (≥10 mg/day), and evidence that 0.3 mg restored sleep efficiency without the hypothermia and daytime melatonin elevation seen with 3 mg.
Methods
- Narrative review; no systematic search strategy or review protocol is reported.
- It synthesizes mechanistic, preclinical, and clinical literature on melatonin mechanisms, clinical uses, safety, dietary sources, supplement formats, dosing, timing, contraindications, and nutrient combinations.
- Evidence discussed includes in vitro cellular assays, animal studies, randomized controlled trials, meta-analyses, systematic reviews, cohort studies, and clinical guidelines; no new primary data are presented.
Limitations
- Stated: there are limited studies to conclude safety of high-dose melatonin (≥10 mg/day); there is a lack of significant data on nutrient combinations; bioavailability of different formats and sources remains unanswered; and in the bone-health combination trial, melatonin cannot be inferred to be responsible for the effects.
- Stated/evident: several clinical areas rely on small, older, or mixed studies—for example, endometriosis results are mixed, shift-work findings are inconsistent or show essentially no benefit, and most jet-lag dosing research is 10–20 years old or older.
- Evident: as a narrative review without systematic search or risk-of-bias assessment, selection and interpretation may be subject to bias; laboratory assessment of melatonin is also confounded by light exposure, timing, diet, season, physical activity, age, sex, genetics, and posture.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 253 cited sources checked · 0 supported · 0 flagged
In the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 3), 267–470% more potent free-radical scavenging ability (see Figure 4), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 5) when compared to synthetic melatonin”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In one of the studies, Akkermansia muciniphila and Lactobacilli species were increased in the melatonin-treated animals [46].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [46] Park, 2020, Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation, Intest Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Both doses of melatonin taken in the morning, approximately 6 h after the sleep midpoint, will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“For instance, 0.5 mg and 3.0 mg of melatonin taken eleven hours before the sleep midpoint will cause a phase advance, so the individual feels sleepy earlier and awakens earlier.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Trials that used higher doses of melatonin and conducted over a longer duration demonstrated even greater effects on these two sleep issues, and overall sleep quality was also significantly improved in melatonin users [1,91].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“A meta-analysis of melatonin for the treatment of primary sleep disorders analyzed nineteen studies involving 1683 individuals.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In 2022, researchers at Harvard Medical School and Brigham and Women’s Hospital explored low (0.3 mg) and high (5 mg) dose melatonin in a relatively small sample of healthy older adults.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In one study, six months of low-dose 2 mg melatonin supplementation taken at the same clock time (between 10–11 pm, personalized to the individual’s chronotype) resulted in a decrease in iRBD symptom severity over the first four weeks of treatment.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [94] Kunz, 2021, Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic, J. Pineal Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“This improvement was maintained over the follow-up period of 4.2 ± 3.1 years [94].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [94] Kunz, 2021, Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic, J. Pineal Res. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Trials that used higher doses of melatonin and conducted over a longer duration demonstrated even greater effects on these two sleep issues, and overall sleep quality was also significantly improved in melatonin users [1,91].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Sleep quality was also significantly improved during and after the study [110,111].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [110] Gelfand, 2016, The Role of Melatonin in the Treatment of Primary Headache Disorders, Headache source
- Not checked yetcites [111] Danilov, 2020, Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program, Pain Ther. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Melatonin was superior to amitriptyline in the percentage of patients with a greater than 50% reduction in migraine frequency, and melatonin was better tolerated than amitriptyline.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A more extensive, longer-term study found that patients with mild cognitive impairment scored better on the Mini-Mental Status Exam and the Sleep Disorders Index when taking melatonin [106].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [106] Furio, 2007, Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Melatonin was superior to amitriptyline in the percentage of patients with a greater than 50% reduction in migraine frequency, and melatonin was better tolerated than amitriptyline.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Overall, significant decreases in pain and tension headache-associated symptoms were observed after melatonin use.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [110] Gelfand, 2016, The Role of Melatonin in the Treatment of Primary Headache Disorders, Headache source
- Not checked yetcites [111] Danilov, 2020, Safety and Efficacy of Melatonin in Chronic Tension-Type Headache: A Post-Marketing Real-World Surveillance Program, Pain Ther. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A randomized, multi-center, parallel-group design was conducted in which melatonin was compared with amitriptyline and placebo for twelve weeks. A 3 mg dose of melatonin reduced migraine frequency, demonstrating the same effectiveness as amitriptyline in the primary endpoint of the frequency of migraine headaches per month [109].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There are distinct similarities between melatonin and vitamin D in the depth and breadth of their impact on health.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
Tests✓ Asserted: passes? Checkable: unclear✓ Load-bearing: passes✓ Based: passesIn the paper
“most likely resulting in the more than doubling of melatonin dietary supplement sales in the U.S. to USD 821 million in 2020 compared with 2017 [1].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Aside from aging, production of melatonin can be influenced by illness [12], diet [4], environmental factors like bright light at night [13], medication use [14], and lifestyle [15].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [12] Maas, 2020, Factors Disrupting Melatonin Secretion Rhythms During Critical Illness, Crit. Care Med. source
- Not checked yetcites [4] Srinivasan, 2006, Melatonin: Nature’s most versatile biological signal?, Febs. J. source
- Not checked yetcites [13] Kubota, 2002, Effects of nocturnal bright light on saliva melatonin, core body temperature and sleep propensity rhythms in human subjects, Neurosci. Res. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Even though the pineal gland receives much attention for its melatonin production, there is 400 times more melatonin in the gut mucosa [5].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [5] Chen, 2011, Distribution, function and physiological role of melatonin in the lower gut, World J. Gastroenterol. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [4] Srinivasan, 2006, Melatonin: Nature’s most versatile biological signal?, Febs. J. source
- Not checked yetcites [11] Karasek, 2006, Melatonin in humans, J. Physiol. Pharmacol.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Children typically produce more melatonin than adults, which may infer that their need for dietary supplementation may require further scrutiny and be limited to specific disease states [4,11].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [4] Srinivasan, 2006, Melatonin: Nature’s most versatile biological signal?, Febs. J. source
- Not checked yetcites [11] Karasek, 2006, Melatonin in humans, J. Physiol. Pharmacol.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [33] Hardeland, R. (2019). Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. Int. J. Mol. Sci., 20. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition, melatonin has the dual capability of targeting receptor-independent and receptor-dependent processes.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Overall, age-related decreases in endogenous melatonin production are correlated with disease and dysfunction.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“It is present in nearly all bodily fluids: cerebrospinal fluid, saliva, bile, synovial fluid, amniotic fluid, urine, feces, semen, and breast milk [16,19,20].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [16] Tan, D.X., Xu, B., Zhou, X., and Reiter, R.J. (2018). Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules, 23. source
- Not checked yetcites [19] Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R.Y., Xu, D.P., and Li, H.B. (2017). Dietary Sources and Bioactivities of Melatonin. Nutrients, 9. source
- Not checked yetcites [20] Sharbatoghli, 2015, The Relationship between Seminal Melatonin with Sperm Parameters, DNA Fragmentation and Nuclear Maturity in Intra-Cytoplasmic Sperm Injection Candidates, Cell J.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In vitro and in vivo studies demonstrate melatonin’s protective ability against mitochondria-mediated injury with hypertension and obesity, suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [33] Hardeland, R. (2019). Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. Int. J. Mol. Sci., 20. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Notably, as stated above, it is a highly efficient antioxidant as one molecule of melatonin can scavenge multiple (~10) reactive oxygen and nitrogen species through a cascading mechanism related to its secondary, tertiary, and even quaternary metabolites [24,31].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [24] Tan, 2007, One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?, J. Pineal Res. source
- Not checked yetcites [31] Ighodaro, 2018, First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid, Alex. J. Med.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Most relevant for the discussion of this paper is that it can bind the vitamin D receptor (VDR), resulting in an enhancement of vitamin D’s signaling effects and subsequent cellular activities [18].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [18] Fang, 2020, Identification of a novel melatonin-binding nuclear receptor: Vitamin D receptor, J. Pineal Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“most likely due to the other constituents found in phytomelatonin such as chlorophyll, beta-carotene, lutein, and other protective, antioxidant phytonutrients [values derived from the original data presented in [34].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Melatonin is colloquially referred to as the “hormone of darkness” since it is produced in response to darkness, as perceived by the eye’s retina [4].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [4] Srinivasan, 2006, Melatonin: Nature’s most versatile biological signal?, Febs. J. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a practical and even clinical perspective, vitamin D and melatonin may act as biochemical sensors to meet requirements for both light and darkness, respectively.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In fact, it has been suggested to be one of the most potent antioxidants because of its ability to scavenge up to 10 reactive oxygen (ROS) and nitrogen species (RNS) with its metabolites compared with most antioxidants, which may only be able to quench a few ROS [16,23,24].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [16] Tan, D.X., Xu, B., Zhou, X., and Reiter, R.J. (2018). Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules, 23. source
- Not checked yetcites [23] Gitto, 2001, Individual and synergistic antioxidative actions of melatonin: Studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates, J. Pharm. Pharmacol. source
- Not checked yetcites [24] Tan, 2007, One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?, J. Pineal Res. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“At the same time, melatonin is an antioxidant in the skin to ward off the damaging effects of UV light.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Melatonin has been found in many tissues other than the pineal gland and gut mucosa, including the brain, retina, lens, cochlea, trachea, skin, liver, kidney, thyroid, pancreas, thymus, spleen, and reproductive tissues [6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [6] Mahmood, 2019, Pleiotropic Effects of Melatonin, Drug Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“For example, it has been demonstrated that melatonin can bind several target proteins, including enzymes, receptors, pores, and transporters [17].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [17] Liu, 2019, Melatonin Target Proteins: Too Many or Not Enough?, Front. Endocrinol. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Rather than respond to the signals of the light/dark cycle or the pineal gland, the mitochondria can induce the production of melatonin based on intracellular need.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is estimated that the enterochromaffin cells within the gut contain upwards of 400 times the amount of melatonin than what is produced by pinealocytes.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“An investigation into gut microbiota has identified microbial influences on the serotonergic and melatonergic systems [25].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Both serotonergic and melatonergic systems are also prone to immune and inflammatory responses, adding to the complexities of the gut-brain axis [44].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [44] Bantounou, M., Plascevic, J., and Galley, H.F. (2022). Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions. Antioxidants, 11. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“There may be the ability to offset some of the decline accompanying the aging process through physiological regeneration with supplemental melatonin, as has been documented in animal and human studies [36].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [36] Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Zhou, X.J., and Xu, B. (2018). Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 23. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to these functions, melatonin facilitates mitochondrial function by encouraging healthy endogenous levels of antioxidant defense enzymes like superoxide dismutase.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Further, melatonin has anti-excitatory properties in the gut.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Levels of gut melatonin can be anywhere from 10 to 100 times greater than melatonin in blood serum levels [37,38].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [37] Zhang, 2022, Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer’s Disease and Obesity, Front. Immunol. source
- Not checked yetcites [38] Laborda-Illanes, A., Sánchez-Alcoholado, L., Boutriq, S., Plaza-Andrades, I., Peralta-Linero, J., Alba, E., González-González, A., and Queipo-Ortuño, M.I. (2021). A New Paradigm in the Relationship between Melatonin and Breast Cancer: Gut Microbiota Identified as a Potential Regulatory Agent. Cancers, 13. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“With the increased production of gastrin, melatonin has also been attributed to increasing the tone of the lower esophageal sphincter [42].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [42] Majka, J., Wierdak, M., Brzozowska, I., Magierowski, M., Szlachcic, A., Wojcik, D., Kwiecien, S., Magierowska, K., Zagajewski, J., and Brzozowski, T. (2018). Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett’s Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives. Int. J. Mol. Sci., 19. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“While low serotonin levels are known to be consistent with clinical depression, low melatonin levels also appear to have a significant connection.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“The broader picture of mental health, specifically depression, has been correlated with melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Preliminary animal research indicates a relationship between gut dysbiosis, endogenous melatonin production, and pathological changes associated with Alzheimer’s disease [37].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [37] Zhang, 2022, Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer’s Disease and Obesity, Front. Immunol. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Along these lines of research, melatonin administration in animals helped reduce dysbiosis due to sleep restriction [45,46].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [45] Wang, 2022, Melatonin prevents the dysbiosis of intestinal microbiota in sleep-restricted mice by improving oxidative stress and inhibiting inflammation, Saudi J. Gastroenterol. source
- Not checked yetcites [46] Park, 2020, Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation, Intest Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Newer data indicate that the mitochondria are pivotal for several aspects of melatonin: its production, metabolism, and activity through receptors [35].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [35] Tan, 2019, Mitochondria: The birth place, battle ground and the site of melatonin metabolism in cells, Melatonin Res. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Mitochondrial dysfunction is one of the mechanisms related to diseases of aging [36].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [36] Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Zhou, X.J., and Xu, B. (2018). Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 23. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“There are initial indications that the antioxidant and anti-inflammatory actions of melatonin may work together with select polyphenols (e.g., resveratrol, epigallocatechin 3-gallate) for therapeutic indications [48,49,50,51,52,53,54].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [48] Tascioglu Aliyev, A., Panieri, E., Stepanić, V., Gurer-Orhan, H., and Saso, L. (2021). Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin. Molecules, 26. source
- Not checked yetcites [49] Labban, 2021, Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease, Behav. Brain Res. source
- Not checked yetcites [50] Aguiar, 2019, Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model, Int. J. Pharm. source
- Not checked yetcites [51] Marhuenda, 2017, Effect of the dietary intake of melatonin- and hydroxytyrosol-rich wines by healthy female volunteers on the systemic lipidomic-related oxylipins, Food Funct. source
- Not checked yetcites [52] Elbe, 2015, Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats, Hum. Exp. Toxicol. source
- Not checked yetcites [53] Zhang, L., He, Y., Wu, X., Zhao, G., Zhang, K., Yang, C.S., Reiter, R.J., and Zhang, J. (2019). Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer. Cells, 8. source
- Not checked yetcites [54] Chattree, V., Singh, K., Singh, K., Goel, A., Maity, A., and Lone, A. (2022). A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID-19 patients by phytotherapeutic melatonin and epigallocatechin-3-gallate. J. Food Biochem., e14259. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“When AhR is triggered, overall endogenous pineal melatonin production is suppressed [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Neurodegenerative conditions share mitochondrial dysfunction in their pathogenesis.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIn the paper
“The melatonin phase response curve specifies how exogenous melatonin will shift the individuals’ body clock when given at various times in relation to their sleep midpoint [65].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [65] Burgess, 2010, Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg, J. Clin. Endocrinol. Metab. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“High concentration levels of kynurenine in the brain are present in instances of depression [32,55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Exercise has been found to increase the throughput in the serotonin-melatonin pathway, eventually increasing both serotonin and melatonin levels and impacting mood and cognition [55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Preliminary research also indicates that it may be an active component in the glymphatic fluid, assisting in removing metabolic waste such as amyloid buildup [61].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [61] Reiter, 2022, Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health, Biochem. Biophys. Res. Commun. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Melatonin supplementation can also modulate the circadian rhythm by causing an advance or delay, depending on the administration time.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Mitochondrial membranes selectively take up melatonin, a function not shared by other antioxidants [63].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [63] Srinivasan, 2011, Melatonin in mitochondrial dysfunction and related disorders, Int. J. Alzheimers Dis. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Human circadian rhythms are entrained to the environmental day primarily by light exposure, particularly at dawn and dusk [64].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [64] Ashton, A., Foster, R.G., and Jagannath, A. (2022). Photic Entrainment of the Circadian System. Int. J. Mol. Sci., 23. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Conversely, acute or chronic inflammation and stress have been found to increase the throughput of the kynurenine pathway, leading to an increase in tryptophan’s conversion to kynurenine [32,55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In addition to the kynurenine pathway, Fila et al. [59] reported that the GI tract is also a major site for tryptophan metabolism.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [59] Fila, M., Chojnacki, J., Pawlowska, E., Szczepanska, J., Chojnacki, C., and Blasiak, J. (2021). Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders. Int. J. Mol. Sci., 22. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Lifestyle factors can result in extrinsic circadian rhythm disorders such as shift work disorder or jet lag disorder [66].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [66] Sateia, M.J. (2014). Disorders. International. Classification of Sleep Disorders, American Academy of Sleep Medicine. [3rd ed.]. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Multiple studies, opinions, and guidelines have suggested melatonin as primary therapy for improved health and sleep of shift workers [69,70,71].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [69] Knutsson, 2003, Health disorders of shift workers, Occup. Med. source
- Not checked yetcites [70] Zee, 2010, Treatment of shift work disorder and jet lag, Curr. Treat. Options. Neurol. source
- Not checked yetcites [71] Morgenthaler, 2007, Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report, Sleep source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Melatonin supplementation has shown promise in a rare sleep disorder, idiopathic REM Behavior Disorder (iRBD).”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [94] Kunz, 2021, Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic, J. Pineal Res. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A decrease in core body temperature is soporific [90].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [90] Reid, 1996, Day-time melatonin administration: Effects on core temperature and sleep onset latency, J. Sleep Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In fact, individuals who are blind tend to have increased abnormalities in circadian rhythm compared with those who have sight [95].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [95] Aubin, 2017, Melatonin and cortisol profiles in the absence of light perception, Behav. Brain Res. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this way, exogenous melatonin can have a direct effect on sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Melatonin has a hypothermic action.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIn the paper
“Of particular mention, one of Lissoni’s studies indicated that melatonin supplementation (20 mg daily, starting seven days before chemotherapy) was helpful in chemotherapy response rate in fifty metastatic non-small cell lung cancer patients [185].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [185] Messina, 2010, Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients, J. Res. Med. Sci.
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“The melatonin content of the 31 over-the-counter melatonin products was found to be −83% to +478% of that listed on the label. [257]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [257] Erland, 2017, Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content, J. Clin. Sleep Med. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A recent meta-analysis and systematic review by researchers at The Chinese University in Hong Kong concluded that a controlled-release oral melatonin supplement reduced asleep systolic blood pressure by 3.57 mm Hg [120].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.2. Cardiometabolic Health
What the sources say
- Not checked yetcites [120] Lee, 2022, Controlled-release oral melatonin supplementation for Hypertension and nocturnal Hypertension: A systematic review and meta-analysis, J. Clin. Hypertens. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A randomized double-blinded placebo-controlled clinical trial with two parallel arms using either placebo or oral 10 mg melatonin supplementation per day for twenty-four weeks in patients with heart failure and reduced ejection fraction observed improvements in endothelial function in those who did not also have diabetes [125].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.2. Cardiometabolic Health
What the sources say
- Not checked yetcites [125] Hoseini, 2021, Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial, Clin. Cardiol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“A recent, relatively small, placebo-controlled study in male diabetics showed reduced insulin sensitivity by 12% after 10 mg of melatonin for three months [126].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.2. Cardiometabolic Health
What the sources say
- Not checked yetcites [126] Lauritzen, 2022, Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial, J. Pineal Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Genetic results suggest a melatonin-signaling deficiency in ADHD [113].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [113] Checa-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., and Muñoz-Hoyos, A. (2021). Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients, 13. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Depleted gut melatonin may be involved in migraine occurrence because of the relative increase in N-acetylserotonin to melatonin ratios, resulting in hyperactive glutamatergic excitatory transmission in migraines.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearIn the paper
“It has also been reported as an effective treatment for primary headache disorders [109].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“One study observed a significantly greater decrease in tinnitus scores on an audiometric test and self-rated tinnitus after treatment with melatonin compared to placebo [112].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [112] Hurtuk, 2011, Melatonin: Can it stop the ringing?, Ann. Otol. Rhinol. Laryngol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Migraines have a solid correlation to altered gut microbiota involving amines and indoles.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A recent study [219] in healthy adults found that Montmorency tart cherries as either juice (2 × 240 mL per day) or as a supplement (two capsules containing 500 mg freeze-dried tart cherry powder) for thirty days did not affect serum melatonin (although it was measured in the morning when levels tend to be low), or sleep time or quality compared with placebo.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.1. Dietary Sources of Melatonin
What the sources say
- Not checked yetcites [219] Hillman, A.R., Trickett, O., Brodsky, C., and Chrismas, B. (2022). Montmorency tart cherry supplementation does not impact sleep, body composition, cellular health, or blood pressure in healthy adults. Nutr. Health, 2601060221111230. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Improvements in LDL cholesterol and blood pressure have been shown in as few as two months of melatonin use (5 mg/day, two hours before bedtime) in thirty patients with documented metabolic syndrome who had not responded to a three-month intervention of therapeutic lifestyle modifications [119].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.2. Cardiometabolic Health
What the sources say
- Not checked yetcites [119] Poliwczak, 2011, Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome, J. Pineal Res. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Cai et al. [124] correlated low levels of endogenous melatonin to decreased long-term survival in patients with pulmonary hypertension.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.2. Cardiometabolic Health
What the sources say
- Not checked yetcites [124] Cai, Z., Klein, T., Geenen, L.W., Tu, L., Tian, S., van den Bosch, A.E., de Rijke, Y.B., Reiss, I.K.M., Boersma, E., and Duncker, D.J. (2020). Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension. J. Clin. Med., 9. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most research on the use of melatonin for jet lag is from 10–20 years ago or longer.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIn the paper
“Higher oral doses (50 mg daily) were given in a subsequent study with immunotherapy to 14 patients with advanced hepatocellular carcinoma [280].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [280] Aldeghi, 1994, Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma, Eur. J. Cancer source
Strength:plain· not yet calibratedn = 14Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A particular proprietary form of phytomelatonin made from alfalfa (Medicago sativa), chlorella powder (Chlorella vulgaris), and rice (Oryza sativa) powders have been shown to contain other phytonutrients in addition to phytomelatonin such as chlorophyll, beta-carotene, isoflavones, phytates, and saponins, all of which are naturally occurring in the plant matrix concentrate [34]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Older clinical studies with smaller subject numbers found no difference [286,287] or modest differences [288] in sleep outcomes compared with placebo.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [286] Wright, 1998, Randomized clinical trial of melatonin after night-shift work: Efficacy and neuropsychologic effects, Ann. Emerg. Med. source
- Not checked yetcites [287] James, 1998, Can melatonin improve adaptation to night shift?, Am. J. Emerg. Med. source
- Not checked yetcites [288] Jorgensen, 1998, Does exogenous melatonin improve day sleep or night alertness in emergency physicians working night shifts?, Ann. Emerg. Med. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Since the average human adult produces between 0.1 mg and 0.9 mg of melatonin daily [277], this range is known as physiological doses.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [277] Scholtens, 2016, Physiological melatonin levels in healthy older people: A systematic review, J. Psychosom. Res. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The low dose in the study did not raise melatonin levels into the normal range.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Controlled-release formulations have been discouraged in older adults due to the possibility of prolonged melatonin levels and unknown implications thereof [273].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [273] Vural, 2014, Optimal dosages for melatonin supplementation therapy in older adults: A systematic review of current literature, Drugs Aging source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Those with certain genotypes, such as polymorphisms in the melatonin receptor 1B (MTNR1B) gene, may require monitoring of hemoglobin A1C if they take supplemental melatonin [275,276].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A recent systematic review and meta-analysis of safety studies on high-dose melatonin (≥10 mg/day) in adults concluded that there are limited studies from which to draw any solid conclusion about its safety profile [274].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [274] Phillips, 2022, Safety of higher doses of melatonin in adults: A systematic review and meta-analysis, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Other studies since these pivotal publications have used this dose as a reference [181,182,183,184].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [181] Elsabagh, 2020, Efficacy of Melatonin in prevention of radiation-induced oral mucositis: A randomized clinical trial, Oral. Dis. source
- Not checked yetcites [182] Johnston, 2019, Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors, Pediatr. Blood Cancer source
- Not checked yetcites [183] Petersen, 2015, Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial, Cancer source
- Not checked yetcites [184] Sookprasert, 2014, Melatonin in patients with cancer receiving chemotherapy: A randomized, double-blind, placebo-controlled trial, Anticancer Res
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“They found the best objective data at 0.3 mg of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In one study, the fast-release formula was more effective than the slow-release preparation [283].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [283] Suhner, 1998, Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag, Chronobiol. Int. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In 2002, Lewy et al. found that physiological doses (0.5 mg) may offer benefits that pharmacologic doses (20 mg) do not [281,282].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
- Not checked yetcites [282] Sack, 2000, Entrainment of free-running circadian rhythms by melatonin in blind people, N. Engl. J. Med. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In fact, those additional constituents may completely or partially explain why this phytomelatonin outperformed synthetic melatonin in cellular assays for inflammation (using COX-2 inhibition) and free radical scavenging [34]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Common contaminants of synthetically produced melatonin, which may or may not be in the final product, include the following compounds [210]:”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [210] Arnao, M.B., and Hernández-Ruiz, J. (2018). The Potential of Phytomelatonin as a Nutraceutical. Molecules, 23. source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In fact, those additional constituents may completely or partially explain why this phytomelatonin outperformed synthetic melatonin in cellular assays for inflammation (using COX-2 inhibition) and free radical scavenging [34]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Finally, to underscore the discussion of dosing in both pediatrics and adults, it is important to understand that melatonin is metabolized via the liver primarily by the enzyme CYP1A2 [292].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [292] Ma, 2005, Metabolism of melatonin by human cytochromes p450, Drug Metab. Dispos. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“While there are many reasons to be concerned about interactions, there may also be a role for melatonin to offset the toxicity of certain drugs through its antioxidant activity [307,308].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [307] Raza, 2020, Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights, Nefrologia source
- Not checked yetcites [308] Shaki, 2016, Melatonin can attenuate ciprofloxacin induced nephrotoxicity: Involvement of nitric oxide and TNF-α, Biomed. Pharmacother. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In a cell assay, vitamin C and phytomelatonin have been shown to demonstrate significant increases in free radical scavenging activity compared to either by themselves [34]; however, those results need to be tested in a clinical trial to be able to extrapolate those findings to humans.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“A meta-analysis [289] found essentially no benefit from melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [289] Buscemi, 2006, Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis, Br. Med. J. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Importantly, melatonin metabolism and activity can be potentially impacted by many dietary, supplemental, and pharmaceutical agents, all of which add to the fact that there is variability in an individual’s personalized response to this compound based on their dietary and medical context.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [306] Therapeutic Research (2022, July 31). Melatonin. Available online: https://naturalmedicines.therapeuticresearch.com/.
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Currently, there is a lack of significant data to make therapeutic suggestions about combinations.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Caution should be exercised when melatonin is taken with one or more medications; otherwise, adverse side effects (like extreme sedation) can result [303].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [303] Foster, 2015, Melatonin Interaction Resulting in Severe Sedation, J. Pharm. Pharm. Sci. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Oral melatonin is mostly perceived as safe based on published reports, even in higher doses [300]; however, there can be specific instances that may necessitate further diligence and clinical oversight.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [300] Foley, 2019, Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence, Complement. Ther. Med. source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Therefore, loss of response after several weeks may suggest a patient’s tolerance of melatonin and necessary dose reduction.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [293] Braam, 2010, Loss of response to melatonin treatment is associated with slow melatonin metabolism, J. Intellect. Disabil. Res. source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Therefore, medications that affect these enzymatic pathways will influence melatonin metabolism.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [292] Ma, 2005, Metabolism of melatonin by human cytochromes p450, Drug Metab. Dispos. source
- Not checked yetcites [302] Huuhka, 2006, The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study, Methods Find Exp. Clin. Pharmacol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Earlier research has identified that the majority of melatonin is metabolized through cytochrome (CYP) 1A2 [292,301], with lesser metabolic activity through CYP1A1, CYP1B1, and CYP2C19 [292,302].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [292] Ma, 2005, Metabolism of melatonin by human cytochromes p450, Drug Metab. Dispos. source
- Not checked yetcites [301] Hidestrand, 2001, Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes, Eur. J. Clin. Pharmacol. source
- Not checked yetcites [302] Huuhka, 2006, The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study, Methods Find Exp. Clin. Pharmacol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Diet: There is still insufficient data about how dietary (exogenous) and gut/pineal (endogenous) sources of melatonin interact and how measurements could be implicated by potential cross-talk among the melatonin inputs.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Promising clinical data indicates that melatonin may help enhance oocytes’ quality.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [312] Rizzo, 2010, Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial, Eur. Rev. Med. Pharmacol. Sci.
- Not checked yetcites [313] Pacchiarotti, 2016, Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome, Gynecol. Endocrinol. source
- Not checked yetcites [314] Wdowiak, 2020, The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: A randomized prospective controlled trial, Eur. Rev. Med. Pharmacol. Sci.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, since people are not likely to adopt the lifestyle of being in such low evening light, the utility of such a test seems limited unless the practitioner wants to verify that the patient’s pineal gland can make melatonin when they are in dim light conditions.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Parsanathan and Jain [316] have demonstrated the effects of glutathione deficiency in high-fat-fed mice with observed epigenetic changes in genes responsible for vitamin D metabolism.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [316] Parsanathan, 2019, Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice, Sci. Rep. source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Combining myo-inositol and folic acid with added melatonin increased oocyte quality in women with PCOS compared with only using myo-inositol and folic acid or folic acid by itself [313].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [313] Pacchiarotti, 2016, Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome, Gynecol. Endocrinol. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, there are many variables to consider with a laboratory assessment that may lead to inaccuracies.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Blue-light-blocking glasses can protect from the melatonin suppressing effects of light [319].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [319] Hester, 2021, Evening wear of blue-blocking glasses for sleep and mood disorders: A systematic review, Chronobiol. Int. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“One study found that adding melatonin to a supplemental protocol of myo-inositol and folic acid may help increase oocyte viability in women undergoing IVF [312].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [312] Rizzo, 2010, Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial, Eur. Rev. Med. Pharmacol. Sci.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Even light of five to ten lux while sleeping with eyes closed will impact the circadian system [318].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [318] Partonen, 2019, Systematic review of light exposure impact on human circadian rhythm, Chronobiol. Int. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Finally, when added to a regimen with vitamin D3, melatonin and myo-inositol were beneficial in oocyte quality, fertilization, and pregnancy outcomes in women undergoing an intracytoplasmic sperm injection [314].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [314] Wdowiak, 2020, The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: A randomized prospective controlled trial, Eur. Rev. Med. Pharmacol. Sci.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 90
- Probably not a substantial claim. 46
- The quote only partly states this claim. 1
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Of note, when melatonin is taken 4 h before the sleep midpoint, i.e., at bedtime, the low dose of 0.5 mg does not shift the circadian rhythm, while the 3.0 mg dose will cause a phase delay.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Both doses improved sleep efficiency, but the higher dose impacted the biological day and night sleep patterns, the duration of non-REM sleep, and awakening time [93].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [93] Duffy, 2022, High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A randomized study of people with delayed sleep-wake phase disorder found that a low dose of melatonin (0.5 mg) an hour before the desired bedtime, along with behavioral strategies for four weeks, resulted in earlier sleep onset, improved sleep efficiency during the first third of the night, and reduced subjective complaints [72].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [72] Sletten, T.L., Magee, M., Murray, J.M., Gordon, C.J., Lovato, N., Kennaway, D.J., Gwini, S.M., Bartlett, D.J., Lockley, S.W., and Lack, L.C. (2018). Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial. PLoS Med., 15. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“A 2017 systematic review [92] identified 5030 studies on melatonin and sleep, but only twelve were included to meet their criteria for randomized, controlled, and single or double-blind studies.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin had a statistically significant effect on reducing sleep latency and increasing total sleep time.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [1] Wunsch, N.-G. (2022, July 31). Sales of Melatonin 2020. Available online: https://www.statista.com/statistics/1267421/sales-of-melatonin-in-the-united-states/.
- Not checked yetcites [91] Qawasmi, 2018, Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders, Focus source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a Cochrane review, nine out of ten trials found that melatonin effectively reduced jet lag symptoms in travelers, especially if traveling eastward or over five time zones [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In a small pilot study of elderly patients with a mild cognitive deficit, the ability to remember previously learned items improved, and depression decreased with melatonin [105].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [105] Zizi, 1998, Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Levels from infancy to adolescence increase and plateau in association with Tanner stages of puberty and then slowly decline with age starting in the late twenties [9,10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“From a basic mechanistic perspective, both have widespread effects on multiple systems and are found extensively throughout the body.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“Breastfed babies have the benefit of melatonin from their mother’s milk [8].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [8] Caba, 2022, Breast Milk and the Importance of Chrononutrition, Front. Nutr. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Like vitamin D, melatonin could plausibly be treated as a required dietary nutrient, with certain individuals necessitating less, more, or fine-tuning to personalized needs for lifestyle requirements (e.g., exposure to artificial blue light at night, jet lag, shift work) or alterations in physiology, such as gene variants in melatonin receptors or metabolic response [2,3].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [2] Celestin, 2021, Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States, J. Pharm. Sci. source
- Not checked yetcites [3] Garaulet, 2015, Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans, Metabolism source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On average, the pineal gland produces between 0.1 and 0.9 mg of melatonin per day [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin production and circadian rhythms do not develop in babies until around three months [7].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [7] Rivkees, 1997, Developing circadian rhythmicity. Basic and clinical aspects, Pediatr. Clin. N. Am. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > Abstract
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Ultraviolet (UV)-B radiation is required to convert 7-dehydrocholesterol in the skin to vitamin D3 [21].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [21] Wacker, 2013, Sunlight and Vitamin D: A global perspective for health, Dermato-Endocrinology source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, vitamin D and melatonin may work synergistically in the skin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Its synthesis is reduced by exposure to light, with artificial light reducing a person’s melatonin production and increasing disease risk [4,6].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It has been proposed that both vitamin D and melatonin orchestrate many of their functions, especially related to redox status, at the level of the mitochondria [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Numerous studies have identified melatonin as a powerful free-radical scavenger with potential protective properties against neurodegenerative disorders, epilepsy, and certain cancers.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Concurrent with the age-related depletions in levels of vitamin D and melatonin, there is mitochondrial dysfunction, which has implications in a variety of clinical conditions that present differently through the seasons with changing light exposure [27].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [27] Ferder, 2020, Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin, J. Steroid Biochem. Mol. Biol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Newer, in vitro data on phytomelatonin would suggest superior antioxidant, anti-radical, and anti-inflammatory effects over synthetic melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Finally, melatonin is involved with multiple activities that include mitochondrial homeostasis, genomic regulation, modulation of inflammatory and immune cytokines, directly impacting both systemic and acute anti-inflammatory properties as well as indications around its potential role in phase separation [25,26].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
- Not checked yetcites [26] Loh, D., and Reiter, R.J. (2021). Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants, 10. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin’s dual actions can inhibit pro-oxidative enzymes (e.g., xanthine oxidase) while also acting to potentiate the critical antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase, and catalase, aiding in the body’s first line of immune defense and metabolic detoxification [31,32].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.1. Mechanisms Related to Aging and Disease: Antioxidant Defense, Oxidative Stress Reduction, and Anti-Inflammatory Properties
What the sources say
- Not checked yetcites [31] Ighodaro, 2018, First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid, Alex. J. Med.
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Of interest, research has indicated that the sheer amplitude of plasma melatonin may not have as much to do with chronological age but more with the degree of pineal calcification and associated melatonin secretion [16].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 1. Introduction
What the sources say
- Not checked yetcites [16] Tan, D.X., Xu, B., Zhou, X., and Reiter, R.J. (2018). Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules, 23. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin assists in mitochondrial redox balance through its ability to reduce the superoxide anion molecule from the electron transport chain and to directly scavenge free radicals [36].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [36] Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Zhou, X.J., and Xu, B. (2018). Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 23. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The established serotonergic and melatonergic systems may be vulnerable before establishing a stable global biota in infancy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“It can stimulate the regeneration of epithelial cells [43] and has also been shown to have protective antioxidant effects on the lining of the GI tract [43].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [43] Kanova, M., and Kohout, P. (2021). Tryptophan: A Unique Role in the Critically Ill. Int. J. Mol. Sci., 22. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It is suspected that the gut-brain axis is a network of complex interactions between the nervous and GI systems with major contributions from intestinal microbiota.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Unlike pinealocytes, enterochromaffin cells are not regulated by light and dark but appear affected by food intake and digestion [39,40].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [39] Rezzani, R., Franco, C., Franceschetti, L., Gianò, M., and Favero, G. (2022). A Focus on Enterochromaffin Cells among the Enteroendocrine Cells: Localization, Morphology, and Role. Int. J. Mol. Sci., 23. source
- Not checked yetcites [40] Yasmin, 2021, Gut melatonin: A potent candidate in the diversified journey of melatonin research, Gen. Comp. Endocrinol. source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Low levels of melatonin may trigger an upregulation in the kynurenine pathway, and kynurenine production, as well as trigger the aryl hydrocarbon receptor (AhR) located on the outer membrane of the mitochondria [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Levels of melatonin are known to be higher in mitochondria compared with blood levels, most likely due to the greater antioxidant requirements with the copious amounts of free radicals generated through the electron transport chain [25].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
What the sources say
- Not checked yetcites [25] Tan, 2015, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Elderly individuals may also be more susceptible to serotonergic and melatonergic system errors due to known lower amounts of biota diversity.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The release of melatonin in the gut acts in a paracrine manner to increase activity and circulation in the gastric mucosa and enhances GI motility [5,41].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
What the sources say
- Not checked yetcites [5] Chen, 2011, Distribution, function and physiological role of melatonin in the lower gut, World J. Gastroenterol. source
- Not checked yetcites [41] Fowler, 2022, Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions, Front. Neurosci. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ultimately, the gut microbiota may influence CNS function and, over time, could cause neurological diseases, including Alzheimer’s disease, mood and anxiety disorders, multiple sclerosis (MS), Parkinson’s disease, and migraines.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.3. Gut-Synthesized Melatonin the Gut Microbiome
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It may be that declining melatonin levels with age and, thus, less protection of the mitochondria from oxidative stress may be contributors to preclinical changes and, ultimately clinical symptoms.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.2. The Central Role of the Mitochondria
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Melatonin is derived from serotonin using 5-hydroxytryptophan (5-HTP) and tryptophan [32,55].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Quinolinic acid is a neurotoxin, while kynurenic acid has neuroprotective properties [32,55,56,57,58].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [55] Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
- Not checked yetcites [57] Reiter, 2010, Neurotoxins: Free radical mechanisms and melatonin protection, Curr. Neuropharmacol. source
- Not checked yetcites [58] Brinkmann, 2019, The Aryl Hydrocarbon Receptor (AhR) in the Aging Process: Another Puzzling Role for This Highly Conserved Transcription Factor, Front. Physiol. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Circadian rhythm sleep-wake disorders are either intrinsic or extrinsic.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Many neurological disorders feature elements of the kynurenine pathway of tryptophan, specifically the dysregulation of tryptophan metabolism and subsequent melatonin production.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This dosing regimen may contribute to the occasional complaints of a paradoxical effect of melatonin supplements on sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin is both water- and lipid-soluble (‘amphiphilic’); thereby, it can freely flow among all bodily tissues, especially across the selective blood–brain barrier, making it likely one of the most formidable antioxidants within the central nervous system [60].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [60] Escames, 2010, The role of mitochondria in brain aging and the effects of melatonin, Curr. Neuropharmacol. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Melatonin supplements can be used therapeutically for both conditions [67].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [67] Auger, 2015, Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline, J. Clin. Sleep Med. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Studies using melatonin have explored how shift work, particularly night work with its exposure to light at night, may increase the risk of cancer, aggravate both gastrointestinal and cardiovascular disease, complicate pregnancy, and interfere with drug therapy [68].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [68] Iguichi, 1982, Age-dependent reduction in serum melatonin concentrations in healthy human subjects, J. Clin. Endocrinol. Metab. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The AhR is responsible for modulating mitochondrial metabolism, melatonergic pathways, acetyl-coenzyme A, and COX-2 prostaglandin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The melatonin-serotonin pathway accounts for approximately five percent of dietary tryptophan degradation, while the kynurenic pathway accounts for approximately 95 percent of dietary tryptophan degradation [32,56].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 2. Scientific Mechanisms > 2.4. Kynurenine Pathway, Energy Regulation Stress Response
What the sources say
- Not checked yetcites [32] Chitimus, D.M., Popescu, M.R., Voiculescu, S.E., Panaitescu, A.M., Pavel, B., Zagrean, L., and Zagrean, A.M. (2020). Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules, 10. source
- Not checked yetcites [56] Maffei, M.E. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int. J. Mol. Sci., 22. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The summary concluded that melatonin is indicated for the following [92]:Insomnia: Immediate release 1–3 mg, 30 min before bed; slow-release can be used for sleep maintenance problemsRegulating sleep in blind individuals who often experience non-24 h sleep-wake rhythm disorder;Replicating the normal endogenous pattern;Delayed sleep phase.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [92] Auld, 2017, Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders, Sleep Med. Rev. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Dysfunctional sleep does not have one mechanism, such as reduced melatonin, but potentially several causes, some or all, may be impacting melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Relatively smaller amounts of melatonin are produced in the retina compared with the pineal gland [96].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [96] Ostrin, 2019, Ocular and systemic melatonin and the influence of light exposure, Clin. Exp. Optom. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Importantly, iRBD is a prodrome biomarker for Parkinson’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, at a larger, more macroscopic level, as mentioned previously, imbalances in melatonin may be associated with what might be referred to as a “darkness deficiency,” or a lack of adequate evening darkness to initiate the secretion of melatonin by the pineal gland.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, interest has been expressed for inflammatory conditions such as ocular neuritis and uveitis [97].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [97] Aranda, 2017, Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases, Curr. Neuropharmacol. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Many studies support melatonin’s use in reducing the ill effects of jet lag and speeding up the normalization of circadian rhythms [73].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [73] Srinivasan, 2008, Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs, Travel. Med. Infect. Dis. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Patients with iRBD will retain muscle tone during REM sleep and can act out their dreams, posing a danger to themselves and others.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, there may be an association between environmental toxins such as heavy metals (e.g., arsenic) and sleep disturbance [82,83].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [82] Rahman, 2022, Association of urinary arsenic and sleep disorder in the US population: NHANES 2015-2016, Environ. Sci. Pollut. Res. Int. source
- Not checked yetcites [83] Shiue, 2017, Urinary arsenic, pesticides, heavy metals, phthalates, polyaromatic hydrocarbons, and polyfluoroalkyl compounds are associated with sleep troubles in adults: USA NHANES, 2005-2006, Environ. Sci. Pollut. Res. Int. source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Some researchers suggest that glaucoma may be a therapeutic target for melatonin [98,99].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [98] Martínez-Águila, A., Martín-Gil, A., Carpena-Torres, C., Pastrana, C., and Carracedo, G. (2021). Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma. Biomolecules, 11. source
- Not checked yetcites [99] Gubin, 2022, Melatonin, circadian rhythms and glaucoma: Current perspective, Neural Regen. Res. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Overall, children diagnosed with ASD and positive family history had higher serum melatonin and nitric oxide levels, with significantly lower malondialdehyde/melatonin ratios, suggesting greater impaired oxidant-antioxidant metabolism and balance in children with ASD [117].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [117] Rana, 2021, The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review, J. Can. Acad. Child Adolesc. Psychiatry
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Overall, clinical data suggest that melatonin supplementation improves sleep and neurotransmission and reduces sundowning in those with Alzheimer’s disease.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a systematic review and meta-analysis of thirteen clinical trials, melatonin supplementation was found to decrease inflammatory compounds (TNF-alpha, IL-6, C-reactive protein), although with a more significant lowering effect on TNF-alpha and IL-6, especially with studies ≥ twelve weeks and at a dosage ≥ 10 mg/day [175].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [175] Zarezadeh, 2020, Melatonin supplementation and pro-inflammatory mediators: A systematic review and meta-analysis of clinical trials, Eur. J. Nutr. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, with the indole structure of melatonin closely resembling that of tryptophan, there could be theoretical safety concerns related to the Eosinophilia-Myalgia Syndrome (EMS) outbreak in 1989 from the intake of at least six contaminants in an L-tryptophan dietary supplement [264,265,266], although the dose of melatonin tends to be about 1000 times lower than that of tryptophan.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [264] Williamson, 1997, Contaminants in commercial preparations of melatonin, Mayo Clin. Proc. source
- Not checked yetcites [265] Williamson, 1998, Structural characterization of contaminants found in commercial preparations of melatonin: Similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome, Chem. Res. Toxicol. source
- Not checked yetcites [266] Allen, 2011, Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan, Arthritis Rheum. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“It was found that autistic patients have low melatonin levels caused by a primary deficit in ASMT gene activity [116].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [116] Melke, 2008, Abnormal melatonin synthesis in autism spectrum disorders, Mol. Psychiatry source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Age-related macular degeneration is another serious ophthalmic condition that theoretically could benefit from melatonin administration, although significant clinical research is currently lacking [100,101].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [100] Rastmanesh, 2011, Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity, Med. Hypotheses source
- Not checked yetcites [101] Mehrzadi, 2020, Mitochondrial dysfunction in age-related macular degeneration: Melatonin as a potential treatment, Expert Opin. Ther. Targets source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Most notable is early research conducted on patients with solid metastatic tumors, in which it was demonstrated that high doses of melatonin were effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.5. (Auto)Immunity
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“At a mechanistic level, it may decrease the progression of the disease through its protection of neuronal cells from amyloid-beta, possibly due to the facilitation of its degradation and transport from the brain matter through the glymphatic fluid [102,103,104].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [102] Lin, 2013, Melatonin in Alzheimer’s disease, Int. J. Mol. Sci. source
- Not checked yetcites [103] Roy, J., Tsui, K.C., Ng, J., Fung, M.L., and Lim, L.W. (2021). Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease. Int. J. Mol. Sci., 22. source
- Not checked yetcites [104] Li, 2020, Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease, Biomed. Pharmacother. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Migraines can also be correlated with many autoimmune disorders tied to melatonin regulation failure. These conditions include Hashimoto’s thyroiditis with associated hypothyroidism, rheumatic diseases, and antiphospholipid syndrome [109].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [109] Ribeiro, 2016, Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention, J. Neurol. Neurosurg. Psychiatry source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Migraine headaches are comorbid with several health conditions, including neurological, psychiatric, cardiovascular, cerebrovascular, GI, metaboloendocrine, and immunological disorders.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A review article found that patients with autism had improved sleep parameters, better daytime behavior, and minimal side effects with melatonin use [118].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 3. Clinical Uses > 3.1. Central Nervous System
What the sources say
- Not checked yetcites [118] Rossignol, 2011, Melatonin in autism spectrum disorders: A systematic review and meta-analysis, Dev. Med. Child. Neurol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For jet lag, recent studies are lacking in detailing the most efficacious dose.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [74] Herxheimer, 2002, Melatonin for the prevention and treatment of jet lag, Cochrane Database Syst. Rev.
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Melatonin may not be effective for everyone.
In the paper
“There have also been reports of vivid dreams or nightmares while using melatonin supplements [164].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [164] Siah, 2014, Melatonin for the treatment of irritable bowel syndrome, World J. Gastroenterol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Interestingly, the control group (not insomniacs) also had low melatonin levels, but melatonin did not improve sleep.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“They concluded that that too much melatonin may negatively affect the melatonin phase-response curve [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Some studies used a protocol in which melatonin supplementation was initiated three days before travel started [284,285].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The pharmacological dose (3 mg), like the lowest dose (0.1 mg), also improved sleep; however, it induced hypothermia and caused plasma melatonin to remain elevated into the daylight hours.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Much has been written about melatonin’s therapeutic value, but the doses used in studies tended to be supraphysiological or based on previous studies that did not have an explicit rationale for choosing the amount.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“The dose of melatonin was patented up to 1 mg based on this earlier research [279], excluding dietary supplement manufacturers from selling this dose and thus, using higher doses.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [279] (1995). National Center for Biotechnology Information. Methods of Inducing Sleep Using Melatonin. (US5449683A), U.S. Patent.
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Melatonin’s action of lowering body temperature is important to monitor and may give significant clues to the appropriate dosage.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In clinical applications, too much melatonin or various extended-release formats have been documented to produce side effects such as amnesia or a “melatonin hangover” the next day, finding it harder to fall asleep, or sleeping well for three to four hours and then waking up and not being able to go back to sleep [275].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [275] Benedict, 2022, Melatonin’s Potential Side Effects: It May Be in Your Genes, Mayo Clin. Proc. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The physiological dose (0.3 mg) restored sleep efficiency and elevated plasma melatonin levels to normal during early adulthood.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [278] Zhdanova, 2001, Melatonin treatment for age-related insomnia, J. Clin. Endocrinol. Metab. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Although more research is needed comparing synthetic and plant-based sources of melatonin, there is some initial indication that phytomelatonin may have advantages related to improved bioavailability and efficacy.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.2. Dietary Supplements
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
- Not checked yetcites [267] Pérez-Llamas, F., Hernández-Ruiz, J., Cuesta, A., Zamora, S., and Arnao, M.B. (2020). Development of a Phytomelatonin-Rich Extract from Cultured Plants with Excellent Biochemical and Functional Properties as an Alternative to Synthetic Melatonin. Antioxidants, 9. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While a theoretical concern, there is a lack of significant scientific evidence that this dependence can develop, and if it does, under which conditions and individuals may be most susceptible.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Lissoni et al.’s cancer research from over twenty years ago demonstrated that 20 mg given intramuscularly followed by oral daily doses of 10 mg was effective in arresting tumor growth and improving quality of life markers [178].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [178] Lissoni, 1991, Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies, Oncology source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This pharmaceutical is a known inhibitor of CYP1A2 and can result in the potentiation of melatonin levels due to reducing its degradation [304].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [304] Wang, 2001, Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin, J. Clin. Psychopharmacol. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In summary, while not a comprehensive listing, melatonin can interact or be influenced by pharmaceuticals, nutrients, or herbs with blood thinning, blood sugar-lowering, blood pressure reducing, anti-convulsing, sedative, anti-depressant, and/or immunosuppressive activities [306].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [306] Therapeutic Research (2022, July 31). Melatonin. Available online: https://naturalmedicines.therapeuticresearch.com/.
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A few human clinical studies published more than two decades ago would suggest that vitamin B12 supplementation increased the phase advance effect of morning light and decreased nocturnal melatonin levels [309,310]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [309] Honma, 1992, Effects of vitamin B12 on plasma melatonin rhythm in humans: Increased light sensitivity phase-advances the circadian clock?, Experientia source
- Not checked yetcites [310] Hashimoto, 1996, Vitamin B12 enhances the phase-response of circadian melatonin rhythm to a single bright light exposure in humans, Neurosci. Lett. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Neither the parents nor children monitored their melatonin use but relied on the initial study proposal, so dosing varied widely.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As stated above, combining melatonin supplementation with actives that influence melatonin pharmacokinetics may cause side effects.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“In one report, clinicians observed that the initial response to melatonin had disappeared weeks after starting treatment, and that the favorable response returned with dose reduction [293].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [293] Braam, 2010, Loss of response to melatonin treatment is associated with slow melatonin metabolism, J. Intellect. Disabil. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, much of the research related to sleep has indicated melatonin supplementation thirty to sixty minutes before bed; yet, some studies have shown that it can be taken up to four hours prior and be effective.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In an average of 3.7 years of follow-up from previous clinical trial participation of pharmacological doses of melatonin, 65% of children were still using melatonin as prescribed in the study, but only 9% were able to discontinue use [290].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Compliance nearly four years later was at 65%, presumably due to the satisfaction of use.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Only one questionnaire-based study investigated long-term melatonin use in children with ADHD and chronic insomnia and, by its design, was based on subjective symptom reports.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [290] Hoebert, 2009, Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia, J. Pineal Res. source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Lewy suggests that dosing for sleep requires a minimum of twelve hours of wakefulness [281].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.4. Timing
What the sources say
- Not checked yetcites [281] Lewy, 2002, Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period, Chronobiol. Int. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The authors would like to emphasize that the dramatic increase in the use of supplemental melatonin in children is unwarranted because they endogenously produce more melatonin than adults [10].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [10] Grivas, 2007, Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis, Scoliosis source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“It is well accepted that melatonin in tablet or capsule form is generally not very bioavailable (1 to 74%) and can be influenced by multiple variables [295].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [295] Savage, R.A., Zafar, N., Yohannan, S., and Miller, J.M.M. (2022). Melatonin. StatPearls, StatPearls Publishing LLC.. StatPearls Publishing. Copyright © 2022.
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“From a pharmacokinetic standpoint, Vasey, McBride, and Penta [297] indicated that melatonin administered in tablet or capsule forms follows first-order or concentration-dependent kinetics. This implies that the kinetic absorption of melatonin is, in fact, not saturable, meaning that larger doses would produce higher plasma concentrations.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Dyssomnia, ADHD, and ASD have been studied and reviewed, all confirming effectiveness and safety of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one. The quote only partly states this claim.
In the paper
“Oral melatonin has been studied to reach peak plasma concentration after forty-one minutes of administration, although it was reported that melatonin pharmacokinetics varied greatly between individuals [297].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [297] Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A systematic review by researchers at the University of Copenhagen cited an average of 15% bioavailability from oral melatonin, which was highly variable (range: 9–33%) and affected by age, illness, caffeine, smoking, and medications [296].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.5. Bioavailability
What the sources say
- Not checked yetcites [296] Andersen, 2015, Clinical pharmacokinetics of melatonin: A systematic review, Eur. J. Clin. Pharmacol. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Historically, due to the lack of safety data, melatonin supplementation was not recommended for women who are pregnant or nursing.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Similarly, caffeine is also metabolized through CYP1A2 and can increase melatonin levels [305].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [305] Ursing, 2003, Caffeine raises the serum melatonin level in healthy subjects: An indication of melatonin metabolism by cytochrome P450(CYP)1A2, J. Endocrinol. Investig. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“It should be noted that studies were of various lengths, with some as short as two weeks, and the longest-lasting study was six months.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Indiscriminate, long-term dosing may lead to unnecessary dependence and even perturbations in puberty onset when nocturnal levels of melatonin tend to decline [291].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.3. Dosing
What the sources say
- Not checked yetcites [291] Boafo, 2019, Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician’s perspective, Nat. Sci. Sleep source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“and in the case of methylcobalamin specifically, may even result in less need for sleep and impart better sleep quality [311]”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [311] Mayer, 1996, Effects of vitamin B12 on performance and circadian rhythm in normal subjects, Neuropsychopharmacology source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Other factors: Season, physical activity, age, gender, genetic factors related to the volume of the active pineal gland, and possibly posture at the time of sample collection may all influence melatonin levels [323].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
What the sources say
- Not checked yetcites [323] Rzepka-Migut, B., and Paprocka, J. (2020). Melatonin-Measurement Methods and the Factors Modifying the Results. A Systematic Review of the Literature. Int. J. Environ. Res. Public Health, 17. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the timing of eating and time of sleep may influence melatonin levels, as can intermittent fasting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It has been shown to have systemic effects through its mechanisms of action, ultimately having the potential for a significant impact on the etiologies of multiple chronic diseases.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“When worn during a 60 min light pulse at 0100 h, blue-light-blocking glasses resulted in a slight increase in melatonin levels compared to baseline, while melatonin levels decreased significantly by 46% in the control condition [320].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [320] Bennett, 2009, Use of modified spectacles and light bulbs to block blue light at night may prevent postpartum depression, Med. Hypotheses source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“When it comes to supplemental sources, phytomelatonin may have greater efficacy and present a more sustainable, low-toxic option compared with synthetic formats of melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
What the sources say
- Not checked yetcites [34] Kukula-Koch, W., Szwajgier, D., Gaweł-Bęben, K., Strzępek-Gomółka, M., Głowniak, K., and Meissner, H.O. (2021). Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties. Molecules, 26. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In healthy adults without sleep or circadian disorders, using blue-light-blocking glasses from 1800 h until bedtime for a week resulted in subjective reports of earlier sleep onset, though objective measures were not improved.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“One recent clinical trial in type 2 diabetics found that modest vitamin D supplementation helped to increase both vitamin D and glutathione levels, while decreasing oxidative stress and inflammation [317].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [317] Gu, 2022, Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes, J. Clin. Lab. Anal. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, lifestyle habits such as proper exposure to light and darkness and less blue light at night are also helpful for establishing healthy melatonin levels.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It remains unclear how food intake (types of foods, macronutrient distribution, timing) during the day can alter pineal gland secretion of melatonin at night;”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“After seven nights of wearing blue blockers for two hours before bed, people with insomnia have significantly improved subjective and objective total sleep time, sleep quality, and soundness [321].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [321] Shechter, 2018, Blocking nocturnal blue light for insomnia: A randomized controlled trial, J. Psychiatr. Res. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a scientific perspective, melatonin acts as a powerful antioxidant that can cross the blood–brain barrier, inhibit inflammation, and interact with the gut microbiome.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, while not yet extensively researched, there could be an interrelationship between the collective antioxidant activities of glutathione, vitamin D, and melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“For people with Delayed Sleep-Wake Phase, wearing blue-light-blocking glasses from 2100 h to bedtime for two weeks resulted in their dim-light melatonin onset occurring 78 min earlier, while sleep onset was significantly earlier by 132 min [322].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.7. Lifestyle Aspects
What the sources say
- Not checked yetcites [322] Esaki, 2016, Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial, Chronobiol. Int. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Various research studies have confirmed that there are individual associations between melatonin and glutathione [165], and glutathione and vitamin D [316].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [165] Muñoz-Jurado, A., Escribano, B.M., Caballero-Villarraso, J., Galván, A., Agüera, E., Santamaría, A., and Túnez, I. (2022). Melatonin and multiple sclerosis: Antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology, 1–28. source
- Not checked yetcites [316] Parsanathan, 2019, Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice, Sci. Rep. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To reduce the risk of inaccuracies, the patient would at least need to abstain from dietary sources of melatonin; however, this is not always practical, and many foods contain melatonin.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Routine laboratories do not tend to offer this type of testing, and of the specialty labs that offer these assessments, there are some confounding factors to consider:”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: Routine laboratories do not tend to offer melatonin testing.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“From a clinical point of view, melatonin imbalance may indicate “darkness deficiency” in much the same way that vitamin D may infer whether or not someone has a “light deficiency”.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Light exposure: Results will be variable and potentially influenced by light conditions. Since melatonin is strongly suppressed by light, the test will not yield many useful data in people’s normal home lighting. It will simply reflect the suppressed levels expected in electric lighting.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.8. A Comprehensive Clinical Approach to Melatonin
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The circadian release of melatonin is strongly suppressed by light, particularly blue light.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, melatonin is an intriguing compound, not unlike vitamin D, which is pleiotropic in activity and responsive to light-dark cycles.”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 5. Conclusions
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
In the paper
“Glutathione is one of the major antioxidant systems in the body and is susceptible to changes in redox status and nutrient supply [315].”
§ Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements > 4. Therapeutic Considerations > 4.6. Contraindications and Combinations
What the sources say
- Not checked yetcites [315] Minich, D.M., and Brown, B.I. (2019). A Review of Dietary (Phyto)Nutrients for Glutathione Support. Nutrients, 11. source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.
“Oxidative stress is one of the leading causes of age-related brain dysfunction by impairing neurogenesis.”
The paper relies on this without support.
The purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source.
“Thus, the purity of a melatonin dietary supplement available to most consumers on the retail store shelf may be debatable or simply unknown without greater diligence to investigate the source, which is often cumbersome and time-consuming.”
The paper relies on this without support.
Larger doses of melatonin do not always confer greater health benefits.
“Larger doses do not always confer greater health benefits.”
The paper relies on this without support.
The upper limits of a lethal dose of melatonin have not been clinically established.
“The upper limits of a lethal dose of melatonin have not been clinically established.”
The paper relies on this without support.
Melatonin is quickly broken down by the body.
“Melatonin is quickly broken down by the body and should be dosed at the appropriate, personalized level for each patient.”
The paper relies on this without support.
Melatonin may not be effective for everyone.
“Melatonin may not be effective for everyone but could be well-suited for those individuals with a history of jet lag and/or for those flying across ≥ five time zones to the East [74].”
The paper relies on this without support.
There is some indication that melatonin may be of benefit during pregnancy and nursing.
“However, there is some indication that melatonin may be of benefit during both these stages.”
The paper relies on this without support.
In certain instances, nutrients may be more effective when included with melatonin or vice versa.
“Conversely, in certain instances, nutrients may be more effective when included with melatonin or vice versa.”
The paper relies on this without support.
Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.
“Type 2 diabetics may be particularly vulnerable to decreases in antioxidants and increases in inflammatory markers.”
The paper relies on this without support.
The circadian release of melatonin is strongly suppressed by light, particularly blue light.
“The circadian release of melatonin is strongly suppressed by light, particularly blue light.”
The paper relies on this without support.
Assessing one's levels of systemic melatonin is difficult.
“From a clinical perspective, assessing one’s levels of systemic melatonin is difficult.”
The paper relies on this without support.
Routine laboratories do not tend to offer melatonin testing.
“Routine laboratories do not tend to offer this type of testing”
The paper relies on this without support.
Melatonin has been misunderstood as a sleep aid.
“To some extent, melatonin has been misunderstood as a sleep aid.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melatonin acts together with vitamin D as “light sensors” to meet the requirements for light and dark (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
In the citing paper
“Interestingly, in 2020–2021, during the COVID-19 pandemic period, melatonin was the most sought-after supplement to optimize levels of cytokines linked with disturbed sleeping (Minich et al. 2022).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Minich et al. 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
A 50 km course is labeled as 31 meters
MinorFifty kilometers is 50,000 meters, not 31 meters. The parenthetical appears to mean 31 miles.
Reported 31 · recomputed 50000
“a 50 km (31 m) course”
Citations
Cites
1 retracted
Pacchiarotti, A., Carlomagno, G., Antonini, G., & Pacchiarotti, A. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101444 · Cited by 111
RetractedThe National Center for Biotechnology Information
Benson, D. A., Boguski, M. S., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,109
Ighodaro, O. M., & Akinloye, O. A. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 4,036 · cited 2×
“Notably, as stated above, it is a highly efficient antioxidant as one molecule of melatonin can scavenge multiple (~10) reactive oxygen and nitrogen species through a cascading mechanism related to its secondary, tertiary, and even quaternary metabolites [24,31].”
BackgroundInternational Classification of Sleep Disorders-Third Edition
Sateia, M. J. (2014) · Chest · doi:10.1378/chest.14-0970 · Cited by 3,860
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 3×
“Phytomelatonin was found to have 646% stronger COX-2 inhibition (see Figure 4), 267–470% more potent free-radical scavenging ability (see Figure 5), and 100% greater efficacy in reducing cellular ROS in a human skin cell line (see Figure 6) when compared to synthetic melatonin, most likely due to the other constituent…”
BackgroundHealth disorders of shift workers
Knutsson, A. (2003) · Occupational Medicine · doi:10.1093/occmed/kqg048 · Cited by 1,218
Sunlight and Vitamin D: A global perspective for health
Wacker, M., & Holick, M. F. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24494 · Cited by 1,156
Dubbels, R., Reiter, R. J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., SCHIWARA, H. W., & Schloot, W. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00136.x · Cited by 1,104
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875 · cited 10×
“Production gradually declines as people age, starting in the late twenties to the fifties, with production leveling at approximately 30 pg/mL [4,11] (see Figure 1).”
BackgroundInfluential
Flagged first, then by citations
19 of the 339 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging
Mladenov, M. I., Lubomirov, L. T., Grisk, O., Avtanski, D. B., Mitrokhin, V. M., Sazdova, I., Keremidarska‐Markova, M., Danailova, Y., Nikolaev, G., Konakchieva, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12051126 · Cited by 79
“In addition, studies have reported the synergistic actions of melatonin with vitamins C and E [215].”
BackgroundLi, W., Li, W., Zhang, W., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03371-y · Cited by 54
Melatonin Treatment in Kidney Diseases
Markowska, M., Niemczyk, S., & Romejko, K. (2023) · Cells · doi:10.3390/cells12060838 · Cited by 44
“Not only is the role of melatonin in human gendering important, its support is also necessary when neonatal pathologies occur [62,63].”
BackgroundThe potential influence of melatonin on mitochondrial quality control: a review
Lei, X., Xu, Z., Huang, L., Huang, Y., Tu, S., Xu, L., & Liu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1332567 · Cited by 36
“In mammals, melatonin is produced in many organs such as the pineal, small intestine, retina, brain, liver, thymus, kidney, skin, and other tissues (Minich et al., 2022).”
BackgroundInfluential
Metadata
- Authors
- Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J.
- Affiliations
- University of Western States (US)
- University of the Rockies (US)
- National University of Natural Medicine (US)
- Bastyr University (US)
- School of Nutrition, Sonoran University of Health Sciences, Tempe, AZ 85282, USA
- Natural Health International Pty., Ltd., Sydney, NSW 2000, Australia
- Corresponding author
- Minich, Deanna M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-09-22
- Volume
- 14
- Issue
- 19
- Pages
- 3934
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9571539
- OpenAlex
- W4296829676
- Semantic Scholar
- e2efdb871a3ef1f27a752431bf3a072a4deb68ea
- Cited by
- 176
- References
- 339
- Citations by year
- 2026: 39 · 2025: 63 · 2024: 37 · 2023: 34 · 2022: 3
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Symphony Natural Health
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melatonin, dietary supplements, sleep, antioxidant activity, immunomodulation, anti-inflammatory activity, mitochondrial regulation, vitamin D, blue light exposure, melatonin deficiency, supplement safety, phytomelatonin, Alzheimer's disease, cancer, multiple sclerosis, polycystic ovary syndrome, fertility, COVID-19 pandemic
- MeSH terms
- COVID-19, Animals, Antioxidants, Circadian Rhythm, Humans, Melatonin, Vitamin D, Vitamins, Dietary Supplements, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review